Everfront Biotech is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases, including brain tumors, pancreatic cancer, and ALS, and is looking for opportunities to cooperate with international pharmaceutical companies or venture capitals.